While probiotics are often used to treat acute gastroenteritis in children, the latest evidence shows no significant differences in outcomes, compared to a placebo. These results come from the large, double-blind, randomized controlled trial conducted at 10 geographically diverse U.S. pediatric emergency departments. Findings were published in the New England Journal of Medicine.
For the first time in the world, researchers at the University of Gothenburg, Sweden, have demonstrated that probiotics, dietary supplements with health-promoting bacteria, can be used to affect the human skeleton. Among older women who received probiotics, bone loss was halved compared to women who received only a placebo. The research opens the door to a new way to prevent fractures among the elderly.
The level of diversity of the ‘good bacteria’ in our digestive systems has been found to be linked to hardening of the arteries – in new research by experts at the University of Nottingham and King’s College London.
Women who take antibiotics for long periods, especially in late adulthood, appear to have a higher risk of death from heart disease and in general, according to preliminary research presented at the American Heart Association’s Epidemiology and Prevention | Lifestyle and Cardiometabolic Health Scientific Sessions 2018, a premier global exchange of the latest advances in population-based cardiovascular science for researchers and clinicians.
According to a survey among researchers, it is difficult to quantify the true extent of the hazards of antibiotic resistances to humankind.
In the gut of patients with heart failure, important groups of bacteria are found less frequently and the gut flora is not as diverse as in healthy individuals. Data obtained by scientists of the German Centre for Cardiovascular Research (DZHK) provide valuable points of departure for understanding how gut colonisation is associated with the development and progress of heart failure.